Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $52.14 million. The enterprise value is $48.93 million.

Market Cap	52.14M
Enterprise Value	48.93M

Important Dates

The next estimated earnings date is Saturday, May 24, 2025, after market close.

Earnings Date	May 24, 2025
Ex-Dividend Date	n/a

Share Statistics

SER has 9.93 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	9.93M
Shares Outstanding	9.93M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-15.23%
Owned by Insiders (%)	30.19%
Owned by Institutions (%)	5.54%
Float	2.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	931.15
Forward PS	n/a
PB Ratio	77.17
P/TBV Ratio	81.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	873.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.91.

Current Ratio	2.40
Quick Ratio	1.55
Debt / Equity	0.91
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-29.60

Financial Efficiency

Return on equity (ROE) is -485.36% and return on invested capital (ROIC) is -221.85%.

Return on Equity (ROE)	-485.36%
Return on Assets (ROA)	-124.04%
Return on Invested Capital (ROIC)	-221.85%
Return on Capital Employed (ROCE)	-357.32%
Revenue Per Employee	$4,308
Profits Per Employee	-$857,000
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-55.11%
50-Day Moving Average	4.84
200-Day Moving Average	6.14
Relative Strength Index (RSI)	54.86
Average Volume (20 Days)	14,626

Short Selling Information

The latest short interest is 30,359, so 0.31% of the outstanding shares have been sold short.

Short Interest	30,359
Short Previous Month	31,112
Short % of Shares Out	0.31%
Short % of Float	1.10%
Short Ratio (days to cover)	2.85

Income Statement

In the last 12 months, SER had revenue of $56,000 and -$11.14 million in losses. Loss per share was -$1.51.

Revenue	56,000
Gross Profit	-7.42M
Operating Income	-15.57M
Pretax Income	-890,146
Net Income	-11.14M
EBITDA	-15.38M
EBIT	-15.57M
Loss Per Share	-$1.51

Full Income Statement

Balance Sheet

The company has $3.67 million in cash and $461,000 in debt, giving a net cash position of $3.21 million or $0.32 per share.

Cash & Cash Equivalents	3.67M
Total Debt	461,000
Net Cash	3.21M
Net Cash Per Share	$0.32
Equity (Book Value)	508,000
Book Value Per Share	0.07
Working Capital	3.31M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.14 million and capital expenditures -$22,000, giving a free cash flow of -$17.16 million.

Operating Cash Flow	-17.14M
Capital Expenditures	-22,000
Free Cash Flow	-17.16M
FCF Per Share	-$1.73

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-27,807.14%
Pretax Margin	-20,012.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	n/a
Earnings Yield	-21.37%
FCF Yield	-32.91%

Analyst Forecast

The average price target for SER is $11.00, which is 109.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.00
Price Target Difference	109.52%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -9.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.6
Piotroski F-Score	n/a